Institutional investors purchased a net $4.0 million shares of INO during the quarter ended March 2014, and now own 15.05% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SMITH ASSET MANAGEMENT GROUP LP Bought 90.1 Thousand shares of Inovio Pharmaceuticals In...